1921
Volume 94, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

The Alere Filariasis Test Strip (FTS) is a qualitative, point-of-care diagnostic tool that detects circulating filarial antigen (CFA) in human blood, serum, or plasma. The Global Program to Eliminate Lymphatic Filariasis employs the FTS for mapping filariasis-endemic areas and assessing the success of elimination efforts. The objective of this study was to explore the relationship between the intensity of positive test lines obtained by FTS with CFA levels as determined by enzyme-linked immunosorbent assay (ELISA) with blood and plasma samples from 188 individuals who live in a filariasis-endemic area. The intensity of the FTS test line was assessed visually to provide a semiquantitative score (visual Filariasis Test Strip [vFTS]), and line intensity was measured with a portable spectrodensitometer (quantitative Filariasis Test Strip [qFTS]). These results were compared with antigen levels measured by ELISA in plasma from the same subjects. qFTS measurements were highly correlated with vFTS scores (ρ = 0.94; < 0.001) and with plasma CFA levels (ρ = 0.91; < 0.001). Thus, qFTS assessment is a convenient method for quantifying CFA levels in human blood, which are correlated with adult worm burdens. This tool may be useful for assessing the impact of treatment on adult filarial worms in individuals and communities.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0916
2016-06-01
2017-09-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/94/6/1324.html?itemId=/content/journals/10.4269/ajtmh.15-0916&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2013. Global programme to eliminate lymphatic filariasis: progress report for 2012. Wkly Epidemiol Rec 37: 389400. Available at: http://www.who.int/wer/2013/wer8837.pdf?ua=1. Accessed December 22, 2015.
  2. Weil GJ, Ramzy RM, , 2007. Diagnostic tools for filariasis elimination programs. Trends Parasitol 23: 7882.[Crossref]
  3. Rebollo MP, Bockarie MJ, , 2014. Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring. Parasitology 141: 19121917.[Crossref]
  4. World Health Organization, 2010. The Global Programme to Eliminate Lymphatic Filariasis: Progress Report 2000–2009 and Strategic Plan 2010–2020. WHO/HTM/NTD/PCT/20106. Available at: http://whqlibdoc.who.int/publications/2010/9789241500722_eng.pdf. Accessed December 22, 2015.
  5. Gass K, Beau de Rochars MV, Boakye D, Bradley M, Fischer PU, Gyapong J, Itoh M, Ituaso-Conway N, Joseph H, Kyelem D, Laney SJ, Legrand AM, Liyanage TS, Melrose W, Mohammed K, Pilotte N, Ottesen EA, Plichart C, Ramaiah K, Rao RU, Talbot J, Weil GJ, Williams SA, Won KY, Lammie P, , 2012. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis 6: e1479.[Crossref]
  6. Weil GJ, Jain DC, Santhanam S, Malhotra A, Kumar H, Sethumadhavan KV, Liftis F, Ghosh TK, , 1987. A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis. J Infect Dis 156: 350355.[Crossref]
  7. More SJ, Copeman DB, , 1990. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol 41: 403406.
  8. Weil GJ, Curtis KC, Fakoli L, Fischer K, Gankpala L, Lammie PJ, Majewski AC, Pelletreau S, Won KY, Bolay FK, Fischer PU, , 2013. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg 89: 1115.[Crossref]
  9. Chesnais CB, Missamou F, Pion SD, Bopda J, Louya F, Majewski AC, Weil GJ, Boussinesq M, , 2013. Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen. Am J Trop Med Hyg 89: 916918.[Crossref]
  10. Pion SD, Chesnais CB, Bopda J, Louya F, Fischer PU, Majewski AC, Weil GJ, Boussinesq M, Missamou F, , 2015. The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo. Am J Trop Med Hyg 92: 959966.[Crossref]
  11. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe K, Abeyewickrema W, Sheriff MR, Rajaratnam HN, Amarasekera N, De Silva DC, Michalski ML, Dissanaike AS, , 1998. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 92: 9497.[Crossref]
  12. Weil GJ, Lammie PJ, Weiss N, , 1997. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 13: 401404.[Crossref]
  13. Altman DG, , 1990. Practical Statistics for Medical Research. London, United Kingdom: Chapman and Hall.
  14. World Health Organization, 2011. Monitoring and Epidemiological Assessment of Mass Drug Administration in the Global Programme to Eliminate Lymphatic Filariasis: A Manual for National Elimination Programmes. WHO/HTM/NTD/PCT/2011.4. Available at: http://whqlibdoc.who.int/publications/2011/9789241501484_eng.pdf. Accessed December 22, 2015.
  15. World Health Organization, 2015. Report of the WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases. Available at: http://www.who.int/neglected_diseases/NTD_STAG_report_2015.pdf. Accessed December 22, 2015.
  16. Harnett W, Worms MJ, Grainger M, Pyke SD, Parkhouse RM, , 1990. Association between circulating antigen and parasite load in a model filarial system, Acanthocheilonema viteae in jirds. Parasitology 101: 435444.[Crossref]
  17. Weil GJ, Chandrashekar R, Liftis F, McVay CS, Bosshardt SC, Klei TR, , 1990. Circulating parasite antigen in Brugia pahangi-infected jirds. J Parasitol 76: 7884.[Crossref]
  18. Weil GJ, Malane MS, Powers KG, , 1984. Detection of circulating parasite antigens in canine dirofilariasis by counterimmunoelectrophoresis. Am J Trop Med Hyg 33: 425430.
  19. Remme J, Ba O, Dadzie KY, Karam M, , 1986. A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ 64: 667681.
  20. Ramzy RM, El-Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ, , 2006. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992999.[Crossref]
  21. Vashist SK, Mudanyali O, Schneider EM, Zengerle R, Ozcan A, , 2013. Cellphone-based devices for bioanalytical sciences. Anal Bioanal Chem 406: 32633277.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0916
Loading
/content/journals/10.4269/ajtmh.15-0916
Loading

Data & Media loading...

  • Received : 22 Dec 2015
  • Accepted : 01 Feb 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error